BIO
Stacy Hurt, M.H.A., M.B.A.
Chief Patient Officer
A globally recognized advocate within the patient community, Stacy champions Parexel’s patients-first culture. She ensures that patients and caregivers have a seat at the table to translate their lived experience and recommendations into improvements in the drug development process at its earliest stages. Stacy champions accessibility to clinical research by expanding the definition of diversity to ensure that people with disabilities have an equitable chance at better treatments, improved outcomes, and cures.
Work Experience
Stacy is an award-winning 25-year pharma executive with experience in functional areas such as sales, marketing, training, operations, and physician practice management. She is a frequent conference speaker and industry influencer, always championing patient involvement in clinical research, for example, as a member of the Global Annual Meeting Program Committee for Drug Information Association (DIA). Stacy is also co-chair of the board of the American Cancer Society Northeast Region (Pittsburgh market).
Education
Stacy holds a bachelor’s degree in labor and industrial relations from Penn State University and master’s degrees in health administration and business administration from the University of Pittsburgh.
2023 Fierce 50 Honoree
Stacy Hurt was included on Fierce Pharma's 2023 Fierce 50 list. Stacy was recognized as a Patient Advocacy Honoree for all of her efforts in amplifying patient voices in the clinical research and development space.